41st
ISICEM

International symposium on intensive care & emergency medicine

March 22-25, 2022

Square -Brussels Convention Center, Brussels

Satellite Symposia

SORT BY

Tuesday March 22 (12:30 - 13:30 CET)

ADVOS therapy - Integrated 4-in-1 Extracorporeal Multi-Organ Support (ECOS)

400 Hall

Tuesday March 22

(12:30- 13:30 CET)

Updates in Haemodynamic Management of Septic Patients

Copper Hall

Tuesday March 22

(12:30- 13:30 CET)

Fluid management in critically ill patients

100 Hall

Tuesday March 22

(12:30- 13:30 CET)

Moving from empirical therapy to early documented antibiotic therapy in ICU patient

The Arc Room

Tuesday March 22

(12:30- 13:30 CET)

Patient safety in the ICU: How AI innovation helps prevent hemodynamic instability

Silver Hall

Tuesday March 22

(12:30- 13:30 CET)

Learnings from the EuroPN study

Tent

Tuesday March 22

(12:30- 13:30 CET)

Challenging cases in the treatment of ICU gram-negative pneumonia

Studio Room

Tuesday March 22

(12:30- 13:30 CET)

Refractory distributive shock: coupling treatment advances with identifying the most appropriate patients

Salle M (Bozar)

Tuesday March 22

(12:30- 13:30 CET)

Managing the risks and challenges of IMD in the ICU

Gold Hall

Tuesday March 22

(12:30- 13:30 CET)

Wednesday March 23 (12:30 - 13:30 CET)

New perspectives on extracorporeal organ support

100 Hall

Wednesday March 23

(12:30- 13:30 CET)

Developing a key to SEPSIS: Clinical performance of MDW

Salle M (Bozar)

Wednesday March 23

(12:30- 13:30 CET)

SEPSIS management & antimicrobial stewerdship

The Arc Room

Wednesday March 23

(12:30- 13:30 CET)

Therapeutic benefits by blood purification – Using COVID-19 as example

Silver Hall

Wednesday March 23

(12:30- 13:30 CET)

Fluid and Nutrition Strategy in the ICU

400 Hall

Wednesday March 23

(12:30- 13:30 CET)

How much is required? - Current guidance on individualized bleeding management in trauma, surgery and ICU

Tent

Wednesday March 23

(12:30- 13:30 CET)

The art of clinical decision-making in the ICU: challenging case studies of MDR Gram-negative infections

Gold Hall

Wednesday March 23

(12:30- 13:30 CET)

aTTP in ICU - An emergency disease requiring early diagnosis and rapid on-set of treatment

Studio Room

Wednesday March 23

(12:30- 13:30 CET)

Thursday March 24 (12:30 - 13:30 CET)

Clinical relevance of IgM-enriched immunoglobulins in COVID-19

Salle M (Bozar)

Thursday March 24

(12:30- 13:30 CET)

Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients

Copper Hall

Thursday March 24

(12:30- 13:30 CET)

Every Hour Counts – Timely Initiation of Anti-infective Treatment in ICU Patients

Silver Hall

Thursday March 24

(12:30- 13:30 CET)

A Comprehensive Platform for Optimizing Oxygen Delivery to match Metabolic Needs of Vital Organs

Tent

Thursday March 24

(12:30- 13:30 CET)

Streamlining the management of CAP – Focus on the ICU

Gold Hall

Thursday March 24

(12:30- 13:30 CET)

Introducing inhaled sedation to intensive care

400 Hall

Thursday March 24

(12:30- 13:30 CET)

Friday March 25 (12:30 - 13:30 CET)

New perspectives on Transient Mechanical Circulatory Support in Cardiogenic Shock Patient

Copper Hall

Friday March 25

(12:30- 13:30 CET)

Mechanical Ventilation De-escalation in the ICU: How to Improve the Weaning Process?

Silver Hall

Friday March 25

(12:30- 13:30 CET)

Are Fibrinogen Sources all the same?

100 Hall

Friday March 25

(12:30- 13:30 CET)

Protein requirements in ICU patients: New clinical trials addressing some unknowns

400 Hall

Friday March 25

(12:30- 13:30 CET)

New perspectives on Transient Mechanical Circulatory Support in Cardiogenic Shock Patient

Copper Hall

Friday March 25

(12:30- 13:30 CET)

ADVOS therapy - Integrated 4-in-1 Extracorporeal Multi-Organ Support (ECOS)

400 Hall

Tuesday March 22

(12:30- 13:30 CET)

Updates in Haemodynamic Management of Septic Patients

Copper Hall

Tuesday March 22

(12:30- 13:30 CET)

Fluid management in critically ill patients

100 Hall

Tuesday March 22

(12:30- 13:30 CET)

New perspectives on extracorporeal organ support

100 Hall

Wednesday March 23

(12:30- 13:30 CET)

Developing a key to SEPSIS: Clinical performance of MDW

Salle M (Bozar)

Wednesday March 23

(12:30- 13:30 CET)

Moving from empirical therapy to early documented antibiotic therapy in ICU patient

The Arc Room

Tuesday March 22

(12:30- 13:30 CET)

SEPSIS management & antimicrobial stewerdship

The Arc Room

Wednesday March 23

(12:30- 13:30 CET)

Clinical relevance of IgM-enriched immunoglobulins in COVID-19

Salle M (Bozar)

Thursday March 24

(12:30- 13:30 CET)

Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients

Copper Hall

Thursday March 24

(12:30- 13:30 CET)

Patient safety in the ICU: How AI innovation helps prevent hemodynamic instability

Silver Hall

Tuesday March 22

(12:30- 13:30 CET)

Learnings from the EuroPN study

Tent

Tuesday March 22

(12:30- 13:30 CET)

Therapeutic benefits by blood purification – Using COVID-19 as example

Silver Hall

Wednesday March 23

(12:30- 13:30 CET)

Mechanical Ventilation De-escalation in the ICU: How to Improve the Weaning Process?

Silver Hall

Friday March 25

(12:30- 13:30 CET)

Every Hour Counts – Timely Initiation of Anti-infective Treatment in ICU Patients

Silver Hall

Thursday March 24

(12:30- 13:30 CET)

Are Fibrinogen Sources all the same?

100 Hall

Friday March 25

(12:30- 13:30 CET)

A Comprehensive Platform for Optimizing Oxygen Delivery to match Metabolic Needs of Vital Organs

Tent

Thursday March 24

(12:30- 13:30 CET)

Challenging cases in the treatment of ICU gram-negative pneumonia

Studio Room

Tuesday March 22

(12:30- 13:30 CET)

Fluid and Nutrition Strategy in the ICU

400 Hall

Wednesday March 23

(12:30- 13:30 CET)

Protein requirements in ICU patients: New clinical trials addressing some unknowns

400 Hall

Friday March 25

(12:30- 13:30 CET)

How much is required? - Current guidance on individualized bleeding management in trauma, surgery and ICU

Tent

Wednesday March 23

(12:30- 13:30 CET)

Refractory distributive shock: coupling treatment advances with identifying the most appropriate patients

Salle M (Bozar)

Tuesday March 22

(12:30- 13:30 CET)

Managing the risks and challenges of IMD in the ICU

Gold Hall

Tuesday March 22

(12:30- 13:30 CET)

The art of clinical decision-making in the ICU: challenging case studies of MDR Gram-negative infections

Gold Hall

Wednesday March 23

(12:30- 13:30 CET)

Streamlining the management of CAP – Focus on the ICU

Gold Hall

Thursday March 24

(12:30- 13:30 CET)

aTTP in ICU - An emergency disease requiring early diagnosis and rapid on-set of treatment

Studio Room

Wednesday March 23

(12:30- 13:30 CET)

Introducing inhaled sedation to intensive care

400 Hall

Thursday March 24

(12:30- 13:30 CET)

100 Hall

Fluid management in critically ill patients

Tuesday March 22

(12:30- 13:30 CET)

New perspectives on extracorporeal organ support

Wednesday March 23

(12:30- 13:30 CET)

Are Fibrinogen Sources all the same?

Friday March 25

(12:30- 13:30 CET)

400 Hall

ADVOS therapy - Integrated 4-in-1 Extracorporeal Multi-Organ Support (ECOS)

Tuesday March 22

(12:30- 13:30 CET)

Fluid and Nutrition Strategy in the ICU

Wednesday March 23

(12:30- 13:30 CET)

Introducing inhaled sedation to intensive care

Thursday March 24

(12:30- 13:30 CET)

Protein requirements in ICU patients: New clinical trials addressing some unknowns

Friday March 25

(12:30- 13:30 CET)

Copper Hall

Updates in Haemodynamic Management of Septic Patients

Tuesday March 22

(12:30- 13:30 CET)

Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients

Thursday March 24

(12:30- 13:30 CET)

New perspectives on Transient Mechanical Circulatory Support in Cardiogenic Shock Patient

Friday March 25

(12:30- 13:30 CET)

Gold Hall

Managing the risks and challenges of IMD in the ICU

Tuesday March 22

(12:30- 13:30 CET)

The art of clinical decision-making in the ICU: challenging case studies of MDR Gram-negative infections

Wednesday March 23

(12:30- 13:30 CET)

Streamlining the management of CAP – Focus on the ICU

Thursday March 24

(12:30- 13:30 CET)

Salle M (Bozar)

Refractory distributive shock: coupling treatment advances with identifying the most appropriate patients

Tuesday March 22

(12:30- 13:30 CET)

Developing a key to SEPSIS: Clinical performance of MDW

Wednesday March 23

(12:30- 13:30 CET)

Clinical relevance of IgM-enriched immunoglobulins in COVID-19

Thursday March 24

(12:30- 13:30 CET)

Silver Hall

Patient safety in the ICU: How AI innovation helps prevent hemodynamic instability

Tuesday March 22

(12:30- 13:30 CET)

Therapeutic benefits by blood purification – Using COVID-19 as example

Wednesday March 23

(12:30- 13:30 CET)

Every Hour Counts – Timely Initiation of Anti-infective Treatment in ICU Patients

Thursday March 24

(12:30- 13:30 CET)

Mechanical Ventilation De-escalation in the ICU: How to Improve the Weaning Process?

Friday March 25

(12:30- 13:30 CET)

Studio Room

Challenging cases in the treatment of ICU gram-negative pneumonia

Tuesday March 22

(12:30- 13:30 CET)

aTTP in ICU - An emergency disease requiring early diagnosis and rapid on-set of treatment

Wednesday March 23

(12:30- 13:30 CET)

Tent

Learnings from the EuroPN study

Tuesday March 22

(12:30- 13:30 CET)

How much is required? - Current guidance on individualized bleeding management in trauma, surgery and ICU

Wednesday March 23

(12:30- 13:30 CET)

A Comprehensive Platform for Optimizing Oxygen Delivery to match Metabolic Needs of Vital Organs

Thursday March 24

(12:30- 13:30 CET)

The Arc Room

Moving from empirical therapy to early documented antibiotic therapy in ICU patient

Tuesday March 22

(12:30- 13:30 CET)

SEPSIS management & antimicrobial stewerdship

Wednesday March 23

(12:30- 13:30 CET)